Novo Nordisk Aktie
| 40,32EUR | -0,84EUR | -2,03% |
WKN DE: A3EU6F / ISIN: DK0062498333
Diese Analysten bewerten die Novo Nordisk-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Barclays Capital | 340,00DKK | 12,96% | 19.02.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 360,00DKK | 19,60% | 12.02.26 | |||
| Jefferies & Company Inc. | 275,00DKK | -8,64% | 12.02.26 | |||
| Deutsche Bank AG | 400,00DKK | 32,89% | 11.02.26 | |||
| UBS AG | 332,00DKK | 10,30% | 06.02.26 | |||
| JP Morgan Chase & Co. | 350,00DKK | 16,28% | 06.02.26 | |||
| Goldman Sachs Group Inc. | 436,00DKK | 44,85% | 22.01.26 | |||
| Bernstein Research | 540,00DKK | 79,40% | 07.11.25 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|